‘Golden age of biotechnology’ comes to Conejo Valley
Westlake Village BioPartners has launched two new funds worth a total of $500 million, bringing the total raised by the firm to more than $820 million since it was founded in 2018.
AeroVironment expands into ground robotics with German acquisition
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash.
Simi Valley’s AeroVironment buys German robotics firm for $45M
AeroVironment, an aerial drone company based in Simi Valley, reached an agreement Dec. 8 to acquire Telerob, a German robotics company, in a deal worth approximately $45.4 million in cash. AeroVironment also released its second quarter 2021 earnings on Dec. 8, revealing an increase in revenue, but a 71% drop in earnings from the previous Read More →
MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
Trade Desk ceiling keeps getting higher
The Trade Desk continues its ascent towards the $1,000 mark, as the torrid stock closed at $890.13 Dec. 1—up 516% since its year low in mid-March.
Semtech reaches record highs after earnings beat
Semtech, a Camarillo semiconductor company specializing in Internet of Things applications, announced earnings on Dec. 2 that beat both the previous quarter and analysts’ estimates. Shares of Semtech were trading at just under $70 my midday on Dec. 3, the highest stock price in the company’s history. The company’s shares are up 23% in the Read More →
Amgen joins new cooperative trials for COVID treatment
With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →
